Jin Matrix ranked among the top searched stocks for 10 days within the past month.

As of 10:32 AM on the 16th, Jin Matrix is trading at 15,250 KRW, up 4.45% from the previous day. This represents a 25.0% increase compared to May 19. Jin Matrix is known as a company specializing in the development of diagnostic agents through biotechnology research.

Over the past five days, individual investors have net purchased 28,968 shares, while foreigners and institutions have net sold 38,501 shares and net purchased 2,165 shares, respectively.

On June 15, Jin Matrix became a market issue with the news of a contract to supply 400 million doses of COVID-19 vaccine with Oxford University and AstraZeneca.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing